Table 1.
Patient characteristics
| Stented prosthesis | Stentless prosthesis | p-value | |
|---|---|---|---|
| N | 14 | 14 | |
| Age (y) | 74 ± 4 | 74 ± 6 | 0.89 |
| Male | 9 (64) | 9 (64) | 1.00 |
| Time after operation (months) | 12 ± 1 | 13 ± 2 | 0.21 |
| Valve size distribution | 0.91 | ||
| 21 mm | 3 (21) | 2 (14) | |
| 23 mm | 6 (43) | 6 (43) | |
| 25 mm | 4 (29) | 4 (29) | |
| 27 mm | 1 (7) | 2 (14) | |
| Concomitant procedures | 3 (21) | 10 (71) | 0.01 |
| CABG | 3 | 9 | |
| MVP+TVP | 0 | 1 | |
| Baseline CMR measurements | |||
| Max. diameter ascending aorta (mm) | 36 (32-40) | 37 (35-38) | 0.67 |
| LVEF (%) | 64 (57-75) | 61 (52-69) | 0.25 |
| Stroke volume (ml) | 89 (75-105) | 85 (69-111) | 0.75 |
| LVEDV (ml) | 130 (124-142) | 149 (122-182) | 0.18 |
| LDEDV corrected for BSA (ml/m2) | 72 (64-81) | 77 (67-87) | 0.31 |
| LVESV (ml) | 45 (34-57) | 50 (43-77) | 0.17 |
CABG coronary artery bypass graft, MVP mitral valve repair, TVP tricuspid valve repair, LVEF left ventricular ejection fraction, LVEDV left ventricular end diastolic volume, corrected LVEDV LVEDV corrected for body surface area, LVESV left ventricular end-systolic volume